ALTAVERE LABS

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Mar 2026 filing date already counts against anyone who files later.

Record

Serial number

99704725

Mark type

Stylized text

Filed

16 Mar 2026

Attorney of record

Scott H. Blackman

Goods and services

• Class 003 — Cosmetics and cleaning preparations: Toothpaste; Tooth powder; Non-medicated mouthwashes; Non-medicated mouth rinse; Breath freshening preparations for personal hygiene; Tooth whitening preparations; Dental bleaching gel; Preparations for cleaning dentures; Cosmetic preparations for the care of mouth and teeth; Non-medicated body care preparations, namely, creams, lotions, gels, and serums; Non-medicated hair care preparations, namely, shampoos, conditioners, and hair lotions
• Class 005 — Pharmaceuticals: Vaccines; Dietary supplements; Nutritional supplements; Vitamin and mineral supplements; Amino acids for nutritional purposes; Probiotic supplements; Prebiotic supplements; Dietetic foods adapted for medical use; Medicated mouthwash; Medicated dental rinses; Medicated toothpaste; Mouthwashes for medical purposes; Dental varnish for use by dentists; Dental cements; Materials for dental fillings; Dental impression materials; Dental adhesives; Hemostatics for medical purposes; Hemostatics for dental purposes; Dental sealants; Wound dressings; Essential oils for aromatherapy use; Pharmaceutical preparations for the treatment and prevention of oral and oropharyngeal cancers; Pharmaceutical preparations for the treatment and prevention of oral potentially malignant disorders, namely, leukoplakia, erythroplakia, and oral submucous fibrosis; Pharmaceutical preparations for the treatment and prevention of periodontal diseases, namely, gingivitis and periodontitis; Medicated preparations for the treatment and prevention of dental caries; Medicated preparations for the treatment and prevention of oral mucositis; Medicated preparations for the treatment and prevention of oral candidiasis and other fungal infections of the oral cavity; Medicated preparations for the treatment and prevention of medication-related osteonecrosis of the jaw (MRONJ); Medicated preparations for the treatment and prevention of temporomandibular joint disorders; Medicated preparations for the treatment and prevention of xerostomia; Medicated preparations for the treatment and prevention of diabetes and metabolic disorders; Medicated preparations for the treatment and prevention of cardiovascular diseases; Medicated preparations for the treatment and prevention of neurodegenerative diseases; Pharmaceutical preparations for the treatment and prevention of autoimmune and inflammatory conditions; Pharmaceutical preparations for the treatment and prevention of bone and joint disorders, namely, osteoporosis and osteoarthritis; Pharmaceutical preparations for the treatment and prevention of infectious diseases; Pharmaceutical preparations for the treatment and prevention of gastrointestinal disorders; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of dermatological conditions; Pharmaceutical preparations for the treatment and prevention of nutritional deficiencies; Pharmaceutical preparations for the treatment and prevention of pain and inflammation; Pharmaceutical preparations for the treatment and prevention of sleep disorders; Pharmaceutical preparations for the treatment and prevention of anxiety and stress-related conditions; Pharmaceutical preparations for the treatment and prevention of immune system disorders; Pharmaceutical preparations for promoting enamel remineralization and strengthening; Pharmaceutical preparations for the treatment of dentinal hypersensitivity; Pharmaceutical preparations for the promotion of oral wound healing; Pharmaceutical preparations for the management of halitosis; Pharmaceutical preparations for the maintenance of oral microbiome balance; Pharmaceutical preparations for prevention and treatment of peri-implant diseases, namely, peri-implantitis; Pharmaceutical preparations for the support for post-surgical oral tissue recovery; Pharmaceutical preparations for promoting gingival tissue regeneration; Pharmaceutical preparations for the management of oral lichen planus; Pharmaceutical preparations for the management of recurrent aphthous ulcers; Pharmaceutical preparations for tooth whitening and stain prevention; Pharmaceutical preparations for general oral and dental hygiene maintenance
• Class 010 — Medical apparatus: Surgical devices and instruments; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Wearable monitors used to measure biometric data for medical use; Body rehabilitation apparatus for medical purposes; Medical imaging apparatus; Dental implants; Orthodontic appliances; Prosthetic instruments for dental purposes; Endodontic apparatus; Medical apparatus and instruments for use in oral and maxillofacial surgical procedures; Medical apparatus and instruments for use in dental diagnostic and imaging procedures; Medical apparatus and instruments for use in endodontic procedures; Medical apparatus and instruments for use in periodontal procedures; Medical apparatus and instruments for use in orthodontic procedures; Medical apparatus and instruments for use in prosthodontic procedures; Medical apparatus and instruments for use in oral cancer screening and detection; Medical apparatus and instruments for use in biopsy and histopathological specimen collection; Medical apparatus and instruments for use in point-of-care diagnostic testing; Medical apparatus and instruments for use in intraoral and extraoral imaging; Medical apparatus and instruments for use in cephalometric and radiographic analysis; Medical apparatus and instruments for use in salivary diagnostics; Medical apparatus and instruments for use in biosensor-based health monitoring procedures
• Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for use in healthcare and life sciences data analysis; Software as a service (SAAS) services featuring software for clinical decision support; Software as a service (SAAS) services featuring software for analysis of medical images and medical imaging data; Software as a service (SAAS) services featuring software for bioinformatics and computational biology data analysis; Software as a service (SAAS) services featuring software for statistical analysis and simulation tools for drug discovery and molecular design; Software as a service (SAAS) services featuring software for statistical analysis and simulation tools for clinical trial design and optimization; Software as a service (SAAS) services featuring software for electronic health record data analytics; Software as a service (SAAS) services featuring software for remote patient monitoring data analytics; Software as a service (SAAS) services featuring software for medical diagnostic and prognostic analytics; Software as a service (SAAS) services featuring software for genomics and multi-omics data analysis; Providing temporary use of on-line non-downloadable software for managing and analyzing biomedical and clinical research data; Providing temporary use of on-line non-downloadable software for laboratory information management; Application service provider featuring application programming interface (API) software; Design and development of computer software; Computer software consultancy; Cloud computing featuring software for use in healthcare and life sciences data management

Owner

• ALTAVERE LABS, LLC, DOVER, DE, US
• Shankargouda Patil, South Jordan, UT, US

Prosecution history

• 10 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 07 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 07 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 07 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 21 Jul 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 21 Jul 2026 — NON-FINAL ACTION E-MAILED
• 21 Jul 2026 — NON-FINAL ACTION WRITTEN
• 18 Jul 2026 — ASSIGNED TO EXAMINER
• 17 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 03 Jun 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 16 Mar 2026 — APPLICATION FILING RECEIPT MAILED
• 16 Mar 2026 — NEW APPLICATION ENTERED